Featured Jobs
|
Daybright Financial
|
|
Independent Retirement
|
|
Regional Sales Director-Heartland July Business Services
|
|
Automotive Industries Trust Funds
|
|
Relationship Manager for Defined Benefit/Cash Balance Plans MM Daybright Financial
|
|
Mergers & Acquisition Specialist Compass
|
|
Relationship Manager â Defined Contributions Daybright Financial
|
|
Daybright Financial
|
|
Independent Retirement
|
|
Director, Strategic Accounts and Channel Development July Business Services
|
|
Compass
|
|
Internal Channel Sales Team Lead July Business Services
|
|
Pentegra
|
|
The Pension Source
|
|
Experienced Employee Benefits Attorney Shipman & Goodwin LLP
|
|
Senior Client Service Specialist EPIC RPS
|
|
Attorney - ERISA, Benefits, & PRT Securian Financial Group
|
|
Regional Sales Director-Mid Atlantic July Business Services
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Press Releases by Date | Press Releases by Company Name
View More Press Releases by Transparency-Rx
|
Press Release New Coalition of Transparent PBM Companies Seeks to Fix Nation's Broken Drug Pricing System |
|
Issued by Transparency-Rx Sept. 19, 2023 |
|
Transparency-Rx embraces Congressional reform, as a catalyst of changes to the PBM market WASHINGTON -- Transparency-Rx (Transparency-Rx.com), a not-for-profit coalition led by transparent pharmacy benefit manager (PBM ) executives, formally launched today. With a forward-looking policy platform, Transparency-Rx embraces many of the anticipated changes to the industry under consideration in Congress and increasingly advanced by state policy makers. Core tenets being championed by Transparency-Rx includes:
At the federal level, policymakers have advanced more than 43 bills impacting both the commercial and public sector markets. Transparency-Rx is working with Democrats, Republicans and the Administration so the strongest PBM reform package is advanced, a distinction from larger competitors opposing reforms. Stated LeAnn Boyd, PharmD, CEO of Liviniti, a leading member of the Transparency-Rx: “Congress should know patients, employers, and plans can thrive in a transparent, competitive, and efficient PBM market. We embrace critical reforms to a costly and misaligned drug pricing market. In fact, most of these reforms are already reflected in the business and innovations of transparent PBMs.” Transparency-Rx’s growing coalition represents over 14.5 million covered lives with operations, employers, patients, and plans in all 50 states. Founding members include:
In an industry that has opposed meaningful drug reform, Transparency-Rx seeks to inject common-sense, change and clarity into a complex environment. |
View More Press Releases by Transparency-Rx
|
Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink. |